Cybin (HELP) Current Assets (2021 - 2026)
Cybin's (HELP) quarterly Current Assets came in at $184.5 million in Q1 2026, up 59.53% YoY from $115.7 million in Q1 2025, and down 17.22% on a QoQ basis from $222.9 million in Q4 2025.
Cybin (HELP) Current Assets (2021 - 2026) Analysis & Trends
Cybin (HELP) has 6 years of Current Assets data on file, last reported at $184.5 million in Q1 2026.
- Quarterly Current Assets rose 59.53% year-over-year to $184.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.5 million (up 59.53% YoY) and the FY2026 annual result came in at $184.5 million, up 59.83% from the prior year.
- Current Assets slipped to $184.5 million in Q1 2026, from $222.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $222.9 million in Q4 2025 to a low of $19.0 million in Q2 2023.
- A 5-year average of $100.0 million and a median of $115.7 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets slumped 59.57% — and 2024, when it soared 674.47%.
- Tracing HELP's Current Assets over 5 years: stood at $22.2 million in 2022, then jumped by 61.35% to $35.8 million in 2023, then soared by 235.44% to $120.0 million in 2024, then jumped by 85.68% to $222.9 million in 2025, then slipped by 17.22% to $184.5 million in 2026.
- The last three Current Assets figures came in at $184.5 million (Q1 2026), $222.9 million (Q4 2025), and $114.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | 184.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184.52 Mn |
| Dec 31, 2025 | 222.90 Mn |
| Sep 30, 2025 | 114.58 Mn |
| Jun 30, 2025 | 143.65 Mn |
| Mar 31, 2025 | 115.67 Mn |
| Dec 31, 2024 | 120.04 Mn |
| Sep 30, 2024 | 131.02 Mn |
| Jun 30, 2024 | 146.79 Mn |
| Mar 31, 2024 | 162.18 Mn |
| Dec 31, 2023 | 35.79 Mn |
| Sep 30, 2023 | 19.95 Mn |
| Jun 30, 2023 | 18.95 Mn |
| Feb 28, 2023 | 31.90 Mn |
| Dec 31, 2022 | 22.18 Mn |
| Sep 30, 2022 | 29.36 Mn |
| Dec 31, 2021 | 54.85 Mn |
| Sep 30, 2021 | 63.12 Mn |
| Jun 30, 2021 | 46.83 Mn |
| Mar 31, 2021 | 52.53 Mn |